[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered ... Forced vital capacity; ICS: Inhaled corticosteroids ...

Current controller drugs for asthma include ICS, LABA, LTRA, omalizumab and theophylline. Current rescue drugs for asthma include short-acting β 2 agonists (SABA), short-acting muscarinic ...

and LABAs with LAMAs and ICS. Using these drugs in combination can often improve long-term control. Within each class of ...

Asthma has a distinct daily rhythm ... in either the run-in or wash-out periods when they were not taking ICS-containing medication, and it would usually be expected that an improvement of ...

mometasone furoate given in a once-daily dose – showed that the two-drug combination performed better than the ICS alone in patients with poorly-controlled asthma. The duo improved lung function ...

The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including salmeterol ... LABA monotherapy (without ICS) may increase risk of asthma-related events (death, hospitalizations ...

Increased risk of asthma-related events (death, hospitalizations, intubations) with LABA monotherapy (without ICS). Do not initiate ... or chronic use of drugs that can reduce bone mass [eg ...

Novartis says that around a third of patients with asthma have symptoms that can’t be controlled using LABA/ICS dual therapy such as GSK’s older drug Seretide – which dominated the market ...